Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395471 · ClinicalTrials.gov registry record · NA
Cytosponge Adequacy Study Evaluation II
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
NCT02395471 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 191 participants.
The verdict
NCT02395471, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
Study Summary
This study will assess the Minimally Invasive Esophageal Cytology Collection System in Patients with Barrett's Esophagus or GERD Symptoms.
Interventions
- DEVICE Cytosponge™ Cell Collection Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02395471
The ClinicalTrials.gov registry entry for NCT02395471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cytosponge™ Cell Collection Device is the first listed.
NCT02395471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02395471 about?
NCT02395471 is a clinical study titled "Cytosponge Adequacy Study Evaluation II". This study will assess the Minimally Invasive Esophageal Cytology Collection System in Patients with Barrett's Esophagus or GERD Symptoms.
What is the current status of trial NCT02395471?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2015-08. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT02395471?
The interventions under investigation include: Cytosponge™ Cell Collection Device (DEVICE).
Who is sponsoring clinical trial NCT02395471?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.